Back to NATIXIS NATIXIS

SYRESYRE
2 quarters

Position history for NATIXISNATIXIS's holdings in Spyre Therapeutics, Inc

NATIXIS previously held 0 shares of SYRE (Spyre Therapeutics, Inc), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$354,908

Total Shares Change

-20,040

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$16.36
0
2025-Q2
New
20,040
-
$354,9080.0%$15.22
33

Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used